Trivedi Global, Inc. with Alan Balmer Announces Research Results of a Proprietary Supplement that Improves Immune Function and Combats Inflammation

Overall immunity increased by greater than 150%


Las Vegas, Nevada, USA, June 02, 2018 (GLOBE NEWSWIRE) -- Alan J. Balmer, an evidence-based healer, today announces research results on the impact of biofield energy treatment on a proprietary nutraceutical product to combat inflammation and autoimmune disorders.

The preclinical research assessed biomarkers for systemic and organ-specific inflammation and blood, as well as, immune function. The following data was reported:

  • Over 150% increase in overall immunity as seen by the rise in antibody levels
  • Over 90% improvement in delayed-type hypersensitivity reaction
  • Over 80% increase in blood cell counts

The research suggests that this proprietary holistic treatment fights against inflammation and improves stress management, as well as, anti-aging, with a safe therapeutic index. Whereas inflammation and stress have been found to be negative contributors to one's overall health, these research findings are promising in showing the nutraceutical's potential to enhance overall health and quality of life.

Overall, the results indicate great promise as a complementary and alternative medicine supplement, with a safe therapeutic index, to combat autoimmune diseases and inflammatory disorders like Celiac Disease (gluten-sensitive enteropathy), Irritable Bowel Syndrome (IBS), Parkinson’s Disease, Graves’ Disease, chronic peptic ulcers, Hepatitis, Addison's Disease, Multiple Sclerosis (MS), Tuberculosis, Rheumatoid arthritis, Chronic periodontitis, Crohn's disease, Ulcerative colitis, Lupus, Vitiligo, Hashimoto Thyroiditis, Chronic sinusitis, Type 1 Diabetes, Asthma, Rheumatoid Arthritis, Sjogren Syndrome, Alopecia Areata, Dermatitis, Psoriasis, Fibromyalgia, Diverticulitis, Chronic Fatigue Syndrome, Alzheimer’s Disease, Atherosclerosis and more. Additionally, the nutraceutical shows promise in the prevention of immune-mediated tissue damage in cases of organ transplants.



Balmer provided this Biofield Energy Healing Treatment as part of a group of seven energy healers. Six were remotely located in the U.S.A and one in Canada. The test formulation was located in the research laboratory of Dabur Research Foundation, near New Delhi, India. The Biofield Energy Treatment was administered for 5 minutes through the healers' unique Biofield Energy Transmission process remotely to the test samples under laboratory conditions. Balmer, as well as, the other six biofield healers participating in this research never visited the laboratory in person, nor had any contact with the nutraceutical samples. 

About Biofield Energy Treatments

The National Center of Complementary and Integrative Health (NCCIH) has recognized and accepted Biofield Energy Healing Treatments as a complementary and alternative medicine (CAM) health care approach in addition to other therapies, medicines, and practices. CAM therapies have been practiced worldwide with reported clinical benefits in different health disease profiles. Human Biofield Energy has subtle energy that has the capacity to work in an effective manner. This energy can be harnessed and transmitted by the gifted into living and non-living things via the process of a Biofield Energy Healing Treatment or Therapy.

Scientific Publication

Title: Immunomodulatory Potential of New Classical Herbomineral Formulation in Experimental Animals: Impact of Biofield Energy Healing Treatment

Journal: Advances in Applied Physiology

Published: December 5, 2017



About Alan Balmer

Alan J. Balmer is a successful businessman who sold his thriving CPA practice and retired in 2014 at the age of 56 to pursue his gifts as a spiritual, holistic medicine-based healer. Balmer attributes his inspiration and impact in the areas of complementary and alternative medicine to his association with Guruji Mahendra Trivedi, founder of Trivedi Global Inc., and the Trivedi Effect®.  Balmer’s healing power is validated in preclinical scientific research using both cell-based and mouse models to suggest benefits from his energy therapy for overall health and well-being, improved quality of life, and increased Vitamin D3 on Bone Health.

About Guruji Mahendra Trivedi & The Trivedi Effect®

Guruji Mahendra Kumar Trivedi, the founder of the Trivedi Effect®, is on a mission to usher in a new era that integrates science, spirituality, and consciousness to vastly improve the human condition and benefit humanity on a global scale. To date, more than 250,000 people worldwide have benefited from the Trivedi Effect®. His organization, Trivedi Global, Inc., is collaborating with globally renowned product research and development organizations to bring to market proprietary products and therapies in the areas of nutraceuticals, pharmaceuticals, and more. Alice Branton, CEO, Trivedi Global, Inc., recently spoke on the impact of the Trivedi Effect® at the Entrepreneurship Club of the Harvard Business School, Nasdaq, Microsoft, and Coca-Cola. She also appeared on more than 35 network television news shows in the last year including ABC, NBC, FOX, CW and more. Dahryn Trivedi, a prodigious spiritual leader, young entrepreneur, inspiring speaker and paradigm-shifting scientist also joins in the mission.

The Trivedi Effect® is an evidence-based phenomenon in which an individual can harness inherently intelligent energy from nature and transmit it to living organisms and non-living materials, anywhere in the world through thought intention, to significantly enhance potency and beneficially alter their characteristics and behaviors through transformation at the atomic, molecular, and cellular levels.

The Trivedi Effect® has been tested, measured, and validated in over 4,000 scientific experiments globally, by world-renowned scientists and research institutes using the rigor of internationally accepted models of scientific research with the most sophisticated technologies available on this planet. Challenging the known frontiers of science, this research has resulted in over 350 publications in major international peer-reviewed scientific journals with over 4,000 citations.

These publications are available in over 3,500 universities internationally including the prestigious Ivy League Universities, as well as, the National Institutes of Health (NIH).



Forward-Looking Statements

This press release contains forward-looking statements. Forward-looking statements involve known and unknown risks and uncertainties, which may cause actual results in future periods to differ materially from stated results. Readers are cautioned that forward-looking statements are not guarantees of future performance or events and, accordingly, are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty of such statements. Statements in this news release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations, and orientations regarding the future. Often, but not always, forward-looking statements can be identified by words such as “may”, “will”, “should”, “would”, “expect”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “predict”, “potential”, “seem”, “seek”, “future”, “continue”, “appear”, or variations of such words including negative variations thereof, and phrases that refer to certain actions, events or results that may, could, would, might or will occur or be taken or achieved.

Attachment


            
Alan J. Balmer

Contact Data